What does the latest research say about the benefits of GLP-1 drugs?

What does the latest research say about the benefits of GLP-1 drugs?

  • Af
  • Episode
      251
  • Published
      11. sep. 2025
  • Forlag
0 Anmeldelser
0
Episode
251 of 252
Længde
25M
Sprog
Engelsk
Format
Kategori
Personlig udvikling

GLP-1 drugs like Ozempic are proven effective for type 2 diabetes and weight management. Researchers are now exploring their potential to reduce heart, kidney, liver, and even Alzheimer’s disease risks. But experts, including obesity specialist Dr. Sean Wharton, warn against off-label use. He breaks down the latest research and what the future might hold.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for What does the latest research say about the benefits of GLP-1 drugs?

Other podcasts you might like ...